Since ancient times, plants have always been a resource of medicines, primarily due to secondary metabolites, which have many pharmacological activities. Many of the drugs used today are based on natural bioactive products or their derivatives (Atanasov et al., 2015). Recently, natural bioactive products, in alternative forms, for instance, extracts, fractions, or phytochemicals, play an essential role in the prevention and treatment of major cancer types (lung, breast, colorectal, etc.) (Atanasov et al., 2015; Kim & Kim, 2018). These compounds exhibit their protective effects in cancer chemoprevention via some pharmacologic activities including antioxidant properties as well as modulating several genes involved in cellular antioxidant defenses, inflammation, metabolism, survival, and proliferation (Battino et al., 2019). Amygdalin (C 20 H 27 NO 11) is a cyanogenic diglycoside that is a secondary plant compound containing nitrile, which after its enzymatic degradation, releases cyanide as the final product